Cargando…
Is combination of neutrophil to lymphocyte ratio and platelet lymphocyte ratio a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma?
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961586/ https://www.ncbi.nlm.nih.gov/pubmed/24665204 http://dx.doi.org/10.2147/OTT.S61552 |
_version_ | 1782308318138597376 |
---|---|
author | Tanoglu, Alpaslan Karagoz, Ergenekon Yiyit, Nurettin Berber, Ufuk |
author_facet | Tanoglu, Alpaslan Karagoz, Ergenekon Yiyit, Nurettin Berber, Ufuk |
author_sort | Tanoglu, Alpaslan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3961586 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-39615862014-03-24 Is combination of neutrophil to lymphocyte ratio and platelet lymphocyte ratio a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma? Tanoglu, Alpaslan Karagoz, Ergenekon Yiyit, Nurettin Berber, Ufuk Onco Targets Ther Letter Dove Medical Press 2014-03-14 /pmc/articles/PMC3961586/ /pubmed/24665204 http://dx.doi.org/10.2147/OTT.S61552 Text en © 2014 Tanoglu et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Letter Tanoglu, Alpaslan Karagoz, Ergenekon Yiyit, Nurettin Berber, Ufuk Is combination of neutrophil to lymphocyte ratio and platelet lymphocyte ratio a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma? |
title | Is combination of neutrophil to lymphocyte ratio and platelet lymphocyte ratio a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma? |
title_full | Is combination of neutrophil to lymphocyte ratio and platelet lymphocyte ratio a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma? |
title_fullStr | Is combination of neutrophil to lymphocyte ratio and platelet lymphocyte ratio a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma? |
title_full_unstemmed | Is combination of neutrophil to lymphocyte ratio and platelet lymphocyte ratio a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma? |
title_short | Is combination of neutrophil to lymphocyte ratio and platelet lymphocyte ratio a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma? |
title_sort | is combination of neutrophil to lymphocyte ratio and platelet lymphocyte ratio a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma? |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961586/ https://www.ncbi.nlm.nih.gov/pubmed/24665204 http://dx.doi.org/10.2147/OTT.S61552 |
work_keys_str_mv | AT tanoglualpaslan iscombinationofneutrophiltolymphocyteratioandplateletlymphocyteratioausefulpredictorofpostoperativesurvivalinpatientswithesophagealsquamouscellcarcinoma AT karagozergenekon iscombinationofneutrophiltolymphocyteratioandplateletlymphocyteratioausefulpredictorofpostoperativesurvivalinpatientswithesophagealsquamouscellcarcinoma AT yiyitnurettin iscombinationofneutrophiltolymphocyteratioandplateletlymphocyteratioausefulpredictorofpostoperativesurvivalinpatientswithesophagealsquamouscellcarcinoma AT berberufuk iscombinationofneutrophiltolymphocyteratioandplateletlymphocyteratioausefulpredictorofpostoperativesurvivalinpatientswithesophagealsquamouscellcarcinoma |